Clinical Trial: DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer
Brief Summary: Palliative radiotherapy for head and neck cancer is widely used but the effect and side effects are largely unknown. We will study the effect of short hypofractionated palliative radiotherapy (20 Gy in 4 fractions) on symptom intensity and -frequency as weel as side effects
Detailed Summary:
Sponsor: University of Aarhus
Current Primary Outcome: Frequency and intensity of symptoms before and after radiotherapy (EORTC C30 and H&N35 questionnaires and CTC AE 3.0 toxicity scores) [ Time Frame: 11 mths ]
Original Primary Outcome: Frequency and intensity of symptoms before and after radiotherapy (EORTC C30 and H&N35 questionnaires and CTC AE 3.0 toxicity scores)
Current Secondary Outcome:
- Survival [ Time Frame: 11 mths ]
- Side effects [ Time Frame: 2 mths ]
- Other treatments [ Time Frame: 11 mths ]
Original Secondary Outcome:
- Survival
- Side effects
- Other treatments
Information By: University of Aarhus
Dates:
Date Received: November 15, 2006
Date Started: November 2006
Date Completion:
Last Updated: June 18, 2013
Last Verified: June 2013